Ambee Pharmaceuticals (DHA:AMBEEPHA) Enterprise Value: BDT0.00 Mil (As of Jul. 03, 2026) ***


DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT754.00
View Full Analysis

What is Ambee Pharmaceuticals Enterprise Value?

Ambee Pharmaceuticals DHA:AMBEEPHA -0.33% 18 Enterprise Value is BDT0.00 Mil as of Jul. 03, 2026. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-EBIT at this moment.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-EBITDA at this moment.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-Revenue at this moment.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its Cash Flow from Operations for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-OCF at this moment.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ambee Pharmaceuticals's Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Ambee Pharmaceuticals's EV-to-FCF at this moment.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Ambee Pharmaceuticals  (DHA:AMBEEPHA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.


Ambee Pharmaceuticals Enterprise Value Related Terms


Ambee Pharmaceuticals Enterprise Value Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Enterprise Value Chart

Ambee Pharmaceuticals Annual Data
Trend
Enterprise Value

Ambee Pharmaceuticals Semi-Annual Data
Enterprise Value

DHA:AMBEEPHA vs IMNPQ: Enterprise Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ambee Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambee Pharmaceuticals Enterprise Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambee Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Ambee Pharmaceuticals's Enterprise Value falls into.


DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Ambee Pharmaceuticals's Enterprise Value for the fiscal year that ended in . 20 is calculated as

Ambee Pharmaceuticals's Enterprise Value for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of BDT0.00 Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Enterprise Value of BDT0.00 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Enterprise Value too high?
Ambee Pharmaceuticals' current Enterprise Value is BDT0.00 Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Enterprise Value compare to IMNPQ?
Ambee Pharmaceuticals' Enterprise Value of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Enterprise Value is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Enterprise Value of BDT0.00 Mil. The current Enterprise Value is BDT0.00 Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Enterprise Value is BDT0.00 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT754.00
Price